173 related articles for article (PubMed ID: 9305709)
41. Telomerase activity in sex cord-stromal tumors of the ovary.
Dowdy SC; O'Kane DJ; Keeney GL; Boyd J; Podratz KC
Gynecol Oncol; 2001 Aug; 82(2):257-60. PubMed ID: 11531276
[TBL] [Abstract][Full Text] [Related]
42. [Relationship between human telomerase reverse transcriptase transcriptional level and telomerase activity in three ovarian cancer cell lines].
Song Y; Kong BH; Liu PS; Ma DX; Jiang S
Ai Zheng; 2003 May; 22(5):486-91. PubMed ID: 12753708
[TBL] [Abstract][Full Text] [Related]
43. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia.
Bechter OE; Eisterer W; Pall G; Hilbe W; Kühr T; Thaler J
Cancer Res; 1998 Nov; 58(21):4918-22. PubMed ID: 9810000
[TBL] [Abstract][Full Text] [Related]
44. Telomerase activity as a marker of breast carcinoma in fine-needle aspirated samples.
Hiyama E; Saeki T; Hiyama K; Takashima S; Shay JW; Matsuura Y; Yokoyama T
Cancer; 2000 Aug; 90(4):235-8. PubMed ID: 10966564
[TBL] [Abstract][Full Text] [Related]
45. [Telomerase as a tumor marker?].
Hummel M; Heine B; Demel G; Stein H
Verh Dtsch Ges Pathol; 1997; 81():312-7. PubMed ID: 9474885
[TBL] [Abstract][Full Text] [Related]
46. [Location expression of human telomerase reverse transcriptase in lung cancer, benign lesion and normal lung tissue].
Wang X; Zhang Z; He M
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Aug; 24(8):461-4. PubMed ID: 11718034
[TBL] [Abstract][Full Text] [Related]
47. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length.
Kojima H; Miyazaki H; Shiwa M; Tanaka Y; Moriyama H
Laryngoscope; 2001 May; 111(5):867-73. PubMed ID: 11359168
[TBL] [Abstract][Full Text] [Related]
48. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro.
Yang SM; Fang DC; Yang JL; Chen L; Luo YH; Liang GP
Eur J Cancer Prev; 2008 Jun; 17(3):209-17. PubMed ID: 18414191
[TBL] [Abstract][Full Text] [Related]
49. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
50. [Diagnostic significance of telomerase activity and telomere length in endoscopic sample of colorectal cancer].
Katayama S; Shiota G; Kawasaki H
Nihon Rinsho; 1998 May; 56(5):1204-8. PubMed ID: 9613123
[TBL] [Abstract][Full Text] [Related]
51. Telomerase activity in gynecologic tumors.
Zheng PS; Iwasaka T; Yamasaki F; Ouchida M; Yokoyama M; Nakao Y; Fukuda K; Matsuyama T; Sugimori H
Gynecol Oncol; 1997 Jan; 64(1):171-5. PubMed ID: 8995569
[TBL] [Abstract][Full Text] [Related]
52. Telomerase activity and telomere length in primary and metastatic tumors from pediatric bone cancer patients.
Sotillo-Piñeiro E; Sierrasesúmaga L; Patiñno-García A
Pediatr Res; 2004 Feb; 55(2):231-5. PubMed ID: 14630995
[TBL] [Abstract][Full Text] [Related]
53. Telomerase activity in gastric cancer.
Hiyama E; Yokoyama T; Tatsumoto N; Hiyama K; Imamura Y; Murakami Y; Kodama T; Piatyszek MA; Shay JW; Matsuura Y
Cancer Res; 1995 Aug; 55(15):3258-62. PubMed ID: 7614459
[TBL] [Abstract][Full Text] [Related]
54. Telomere shortening in renal cell carcinoma.
Mehle C; Ljungberg B; Roos G
Cancer Res; 1994 Jan; 54(1):236-41. PubMed ID: 8261445
[TBL] [Abstract][Full Text] [Related]
55. Telomerase activity in benign endometrium and endometrial carcinoma.
Brien TP; Kallakury BV; Lowry CV; Ambros RA; Muraca PJ; Malfetano JH; Ross JS
Cancer Res; 1997 Jul; 57(13):2760-4. PubMed ID: 9205088
[TBL] [Abstract][Full Text] [Related]
56. Telomerase in the ovary.
Liu JP; Li H
Reproduction; 2010 Aug; 140(2):215-22. PubMed ID: 20562297
[TBL] [Abstract][Full Text] [Related]
57. Nonradioisotopic telomeric repeat amplification protocol (TRAP) using digoxigenin labeled probe.
Wada Y; Yagihashi A; Kameshima H; Matsuura A; Sato N; Kikuchi K; Yajima T; Sasaki K; Uehara N; Watanabe N; Hirata K
Immunopharmacol Immunotoxicol; 1997 Nov; 19(4):451-7. PubMed ID: 9436045
[TBL] [Abstract][Full Text] [Related]
58. [Methods of measuring telomere length and telomerase activity--practice and problems].
Saito Y; Suda T; Hatakeyama K
Nihon Rinsho; 1998 May; 56(5):1153-8. PubMed ID: 9613113
[TBL] [Abstract][Full Text] [Related]
59. Telomerase activity in normal and malignant murine tissues.
Chadeneau C; Siegel P; Harley CB; Muller WJ; Bacchetti S
Oncogene; 1995 Sep; 11(5):893-8. PubMed ID: 7675448
[TBL] [Abstract][Full Text] [Related]
60. Telomerase activity in germ cell cancers and mature teratomas.
Albanell J; Bosl GJ; Reuter VE; Engelhardt M; Franco S; Moore MA; Dmitrovsky E
J Natl Cancer Inst; 1999 Aug; 91(15):1321-6. PubMed ID: 10433622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
